Down-regulation of miR-23a inhibits high glucose-induced EMT and renal fibrogenesis by up-regulation of SnoN
出版年份 2017 全文链接
标题
Down-regulation of miR-23a inhibits high glucose-induced EMT and renal fibrogenesis by up-regulation of SnoN
作者
关键词
Diabetic nephropathy, MicroRNA-23a, High glucose, Epithelial–mesenchymal transition, Renal fibrogenesis, SnoN
出版物
Human Cell
Volume 31, Issue 1, Pages 22-32
出版商
Springer Nature
发表日期
2017-07-13
DOI
10.1007/s13577-017-0180-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- SnoN upregulation ameliorates renal fibrosis in diabetic nephropathy
- (2017) Lirong Liu et al. PLoS One
- MicroRNA-23a regulates epithelial-to-mesenchymal transition in endometrial endometrioid adenocarcinoma by targeting SMAD3
- (2016) Ping Liu et al. Cancer Cell International
- Oxymatrine Inhibits Renal Tubular EMT Induced by High Glucose via Upregulation of SnoN and Inhibition of TGF-β1/Smad Signaling Pathway
- (2016) Lirong Liu et al. PLoS One
- Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate-induced epithelial mesenchymal transition (EMT) of renal tubular cells
- (2016) Rattiyaporn Kanlaya et al. Scientific Reports
- SnoN as a novel negative regulator of TGF-β/Smad signaling: a target for tailoring organ fibrosis
- (2015) Matthew R. Zeglinski et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- MicroRNA-23a enhances migration and invasion through PTEN in osteosarcoma
- (2015) K Tian et al. CANCER GENE THERAPY
- Transcription Factor Egr1 is Involved in High Glucose-Induced Proliferation and Fibrosis in Rat Glomerular Mesangial Cells
- (2015) Dan Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- miR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1
- (2015) Guangbin Wang et al. TUMOR BIOLOGY
- MiR-23a Functions as a Tumor Suppressor in Osteosarcoma
- (2014) Yu He et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy
- (2013) Yan-Ming Sun et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Knockdown of thioredoxin-interacting protein ameliorates high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells
- (2013) Jinying Wei et al. CELLULAR SIGNALLING
- miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes
- (2013) X. Zhong et al. DIABETOLOGIA
- miR-23a Targets Interferon Regulatory Factor 1 and Modulates Cellular Proliferation and Paclitaxel-Induced Apoptosis in Gastric Adenocarcinoma Cells
- (2013) Xue Liu et al. PLoS One
- MicroRNA regulatory networks and human disease
- (2012) Yin-Yuan Mo CELLULAR AND MOLECULAR LIFE SCIENCES
- MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells
- (2012) MENGRU CAO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Diabetic Nephropathy and Extracellular Matrix
- (2012) S. O. Kolset et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Can We Target Tubular Damage to Prevent Renal Function Decline in Diabetes?
- (2012) Joseph V. Bonventre SEMINARS IN NEPHROLOGY
- The Role of the p38 MAPK Signaling Pathway in High Glucose-Induced Epithelial-Mesenchymal Transition of Cultured Human Renal Tubular Epithelial Cells
- (2011) Zhi-Mei Lv et al. PLoS One
- miR-200a Prevents Renal Fibrogenesis Through Repression of TGF- 2 Expression
- (2010) B. Wang et al. DIABETES
- MicroRNA Control in the Immune System: Basic Principles
- (2009) Changchun Xiao et al. CELL
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
- (2009) Y. Liu JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ski and SnoN, potent negative regulators of TGF-β signaling
- (2008) Julien Deheuninck et al. CELL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started